ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Press Release
DC Healthcare Rides the Wave of Success with New Openings at Publika and Bukit Indah
Apr 18, 2024 19:33 JST
More info..
DC Healthcare Continues Growth Momentum with Second DC Body Outlet Opening in USJ Taipan
Mar 25, 2024 19:00 JST
DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, continues the Group's growth momentum to announcing the opening of the latest DC Body outlet in USJ Taipan.
More info..
DC Healthcare Further Expands into Perai, Pulau Pinang with Two New Outlets, and Introduces DC Body
Feb 29, 2024 11:20 JST
DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, is pleased to announce the opening of two new outlets: Dr Chong Clinic and DC Body, both located in Perai Pulau Pinang (Auto City).
More info..
DC Healthcare Announces Expansion with New Branches in Johor Bahru and Ipoh
Feb 21, 2024 20:00 JST
DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, is pleased to announce the openings of the Group's new branches in Johor Bahru (Taman Molek), and Ipoh (Bandar Seri Botani).
More info..
DC Healthcare Unveils Innovative Skincare Range 'newB' Under Subsidiary Ten Doctors Sdn Bhd
Nov 01, 2023 19:00 JST
More info..
DC Healthcare Debuts on ACE Market with a Premium of RM0.15 over IPO Price
Jul 17, 2023 11:00 JST
DC Healthcare Holdings Berhad, an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, today debuted on the ACE Market of Bursa Malaysia Securities Berhad, opening at RM0.40 per share representing a premium of 60% over the initial public offering (IPO) price of RM0.25 per share.
More info..
1
Latest Release
12 New Companies Join Toyota Woven City as Inventors
Aug 04, 2025 21:09 JST
Honda HRC Wins 46th Suzuka 8 Hours Endurance Road Race
Aug 04, 2025 20:43 JST
MUFG Bank and Fujitsu collaborate on preventive health ecosystem to address societal challenges
Aug 04, 2025 11:00 JST
Hitachi completes capital reorganization of air conditioning joint venture accelerating the deployment of green cooling solutions through "One Hitachi"
Aug 01, 2025 19:00 JST
Mitsubishi Motors and Security Bank launch Mitsubishi Motors Finance Philippines Inc.
Aug 01, 2025 17:00 JST
Honda Turkiye A.S. decided to establish Motorcycle Production Factory
Aug 01, 2025 16:45 JST
Honda Begins Joint Demonstration of Stationary Fuel Cell Power Station Designed to Utilize By-product Hydrogen and Repurposed Automotive Fuel Cells
Aug 01, 2025 11:20 JST
Isuzu's first battery-electric pickup "D-MAX EV" adopts eAxle
Aug 01, 2025 11:00 JST
Fujitsu starts official development of plus-10,000 qubit superconducting quantum computer targeting completion in 2030
Aug 01, 2025 10:20 JST
Revenue of LEQEMBI(R) (Preliminary Basis)
Jul 31, 2025 18:27 JST
Transfer of Sharp Mie Plant No.2 and part of the land at Mie Base
Jul 31, 2025 17:11 JST
TANAKA PRECIOUS METAL GROUP Announces Business Partnership with JEPLAN to Realize a Decarbonized, Circular Society
Jul 31, 2025 15:00 JST
DENSO Announces First Quarter Financial Results
Jul 31, 2025 11:25 JST
Honda Launches All-New Prelude Teaser Page Ahead of Scheduled September 2025 Market Introduction
Jul 31, 2025 11:20 JST
MHI Demonstrates Transport of Relief Supplies in the Event of a Disaster Using Uncrewed Aerial Vehicles Currently in Development
Jul 31, 2025 11:00 JST
Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
Jul 31, 2025 09:30 JST
New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
Jul 31, 2025 09:20 JST
Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
Jul 31, 2025 09:10 JST
Introducing the Meshy 5 Preview: Smarter AI, Cleaner Models, Bigger Animation Potential
Jul 30, 2025 22:41 JST
Production, Sales and Export Results for June, 2025
Jul 30, 2025 18:24 JST
More Latest Release >>